Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab (ReAct) in Active Rheumatoid Arthritis
NCT00448383Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2002
- Primary completion
- Nov 2004
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Sep 2002; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00448383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448383.